-- Glarun Technology's (SHA:600562) attributable profit slipped to 628.5 million yuan in 2025 from 629.8 million yuan in 2024, according to a Thursday filing with the Shanghai bourse.
Earnings per share at the radar manufacturer stayed flat at 0.51 yuan.
Operating income slipped 1.3% year over year to 3.36 billion yuan from 3.40 billion yuan.
Lucid Diagnostics (LUCD) said Friday that is has completed its underwritten direct offering of 18 million shares at $1 per share.The company said the offering was anchored by a $15 million investment from a "fundamental" institutional investor with support from a large existing shareholder.Lucid said it plans to use the net proceeds for working capital and general corporate purposes.Price: $1.09, Change: $-0.01, Percent Change: -0.46%
Dover (DOV) reported a modest Q1 operating beat, with 24% bookings growth and a 1.20x book-to-bill ratio pointing to demand momentum, RBC Capital Markets said in a Thursday note.The firm said bookings strength was broad-based, with all segments posting book-to-bill above 1.10x.RBC highlighted strength in clean energy components, fluid transport, retail fueling, refrigerated door cases, heat exchangers and CO2 refrigeration systems.The firm also said bookings strength suggests upside to Dover's 3% to 5% organic growth guidance. Dover reaffirmed its 2026 adjusted earnings per share guidance of $10.45 to $10.65, and revenue growth outlook of 5% to 7%.RBC raised its price target to $252 from $225, and maintained its sector perform rating on Dover.Price: $229.96, Change: $+1.81, Percent Change: +0.79%
Anne Lesage, Chief Early Development Officer, on April 22, 2026, sold 14,700 shares in Pharvaris (PHVS) for $441,726. Following the Form 4 filing with the SEC, Lesage has control over a total of 213,319 common shares of the company, with 56,450 shares held directly and 156,869 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1830487/000119312526176222/xslF345X05/ownership.xmlPrice: $28.49, Change: $+1.20, Percent Change: +4.40%